BioAtla, Inc.

BCABNASDAQ Global Market·USD·Closed

BCABNASDAQ·USD·Closed

$3.46

+1.76%

$3.46

+$0.06 (1.76%)

52W Range

0thpctl

Volume

0.22×avg

Mkt Cap

4.36MUSD

P/E

-0.1TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

0thpctl

Volume

0.22×avg

Market Cap

4.36MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-81.8% / yr

Operating margin-2525.0%

ROIC477.9%

Financially safe

Stretched

Debt / equity-0.16×

Interest coverage0.0×

Current ratio0.15×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required